Technical Analysis for ACUR - Acura Pharmaceuticals, Inc.
Trend Table & Recent Alerts
|Weak or Absent||Down||Down||Up|
|See historical ACUR trend table...|
|Date||Alert Name||Type||% Chg|
|Mar 24||Narrow Range Bar||Range Contraction||0.00%|
|Mar 24||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Mar 23||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Mar 22||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Mar 21||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||16.00%|
|Mar 20||Narrow Range Bar||Range Contraction||1.75%|
|Mar 20||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||1.75%|
|Mar 17||Narrow Range Bar||Range Contraction||1.75%|
|Mar 17||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||1.75%|
|Mar 16||Shooting Star Candlestick||Bearish||5.45%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the companys proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Is ACUR a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACUR news...
|52 Week High||3.52|
|52 Week Low||0.46|
|200-Day Moving Average||1.2383|
|50-Day Moving Average||0.6512|
|20-Day Moving Average||0.5345|
|10-Day Moving Average||0.552|
|Average True Range||0.0871|
|Chandelier Exit (Long, 3 ATRs)||0.4887|
|Chandelier Exit (Short, 3 ATRs)||0.7213|
|Upper Bollinger Band||0.596|
|Lower Bollinger Band||0.473|
|Percent B (%b)||0.87|